Telebrands to pay $515,000 to settle multi-state suit involving Whisper XL false claims.
This article was originally published in The Gray Sheet
TELEBRANDS TO PAY $515,000 TO SETTLE CONSUMER FRAUD SUIT brought by 17 state's attorney generals involving the sale and advertisement of the firm's Whisper XL hearing enhancement device. Under the terms of consent judgments filed in all 17 states July 30, Fairfield, New Jersey-based Telebrands agrees to pay a total of $515,000 in penalties and costs to the states and to refrain from selling or advertising the Whisper until it receives marketing approval for the device from FDA.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.